![Gregory Stein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregory Stein
Fundador en Curtana Pharmaceuticals, Inc. .
Cargos activos de Gregory Stein
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Revolutions, Inc.
![]() Revolutions, Inc. Packaged SoftwareTechnology Services Revolutions, Inc. is an internet retail website development and management company. The private company is based in Columbus, OH. The company was founded in 2000. | Director/Miembro de la Junta | - | - |
Curtana Pharmaceuticals, Inc.
![]() Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curtana Pharmaceuticals, Inc. is a preclinical-stage biopharmaceutical company, which engages in the provision of therapies for the treatment of brain cancer. It focuses on the development of small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma and other brain cancers. The company was founded by Gregory Stein in 2013 and is headquartered in Austin, TX. | Director/Miembro de la Junta | 01/01/2013 | - |
Director Ejecutivo | 01/01/2013 | - | |
Fundador | 01/01/2013 | - |
Historial de carrera de Gregory Stein
Antiguos cargos conocidos de Gregory Stein.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PLUS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/04/2020 | 01/04/2021 |
Genoptix, Inc.
![]() Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Ventas & Marketing | - | - |
Sova Pharmaceuticals, Inc.
![]() Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Director de Operaciones | 01/01/2010 | 30/11/2011 |
Director Técnico/Científico/I+D | 01/01/2010 | - | |
Fundador | 01/01/2010 | - |
Formación de Gregory Stein.
The Ohio State University | Undergraduate Degree |
Rady School of Management at UC San Diego | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Director/Board Member | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PLUS THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Genoptix, Inc.
![]() Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Health Technology |
Revolutions, Inc.
![]() Revolutions, Inc. Packaged SoftwareTechnology Services Revolutions, Inc. is an internet retail website development and management company. The private company is based in Columbus, OH. The company was founded in 2000. | Technology Services |
Sova Pharmaceuticals, Inc.
![]() Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Health Technology |
Curtana Pharmaceuticals, Inc.
![]() Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curtana Pharmaceuticals, Inc. is a preclinical-stage biopharmaceutical company, which engages in the provision of therapies for the treatment of brain cancer. It focuses on the development of small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma and other brain cancers. The company was founded by Gregory Stein in 2013 and is headquartered in Austin, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory Stein
- Experiencia